Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 1
2005 1
2007 1
2012 1
2014 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Comprehensive tumor molecular profile analysis in clinical practice.
Özdoğan M, Papadopoulou E, Tsoulos N, Tsantikidi A, Mariatou VM, Tsaousis G, Kapeni E, Bourkoula E, Fotiou D, Kapetsis G, Boukovinas I, Touroutoglou N, Fassas A, Adamidis A, Kosmidis P, Trafalis D, Galani E, Lypas G, Orhan B, Tansan S, Özatlı T, Kırca O, Çakır O, Nasioulas G. Özdoğan M, et al. Among authors: touroutoglou n. BMC Med Genomics. 2021 Apr 14;14(1):105. doi: 10.1186/s12920-021-00952-9. BMC Med Genomics. 2021. PMID: 33853586 Free PMC article.
Thymidylate synthase inhibitors.
Touroutoglou N, Pazdur R. Touroutoglou N, et al. Clin Cancer Res. 1996 Feb;2(2):227-43. Clin Cancer Res. 1996. PMID: 9816165 Free article. Review.
Rectal cancer: multimodal treatment approach.
Pramateftakis MG, Kanellos D, Tekkis PP, Touroutoglou N, Kanellos I. Pramateftakis MG, et al. Among authors: touroutoglou n. Int J Surg Oncol. 2012;2012:279341. doi: 10.1155/2012/279341. Epub 2012 Sep 12. Int J Surg Oncol. 2012. PMID: 23008766 Free PMC article. No abstract available.
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.
Negru S, Papadopoulou E, Apessos A, Stanculeanu DL, Ciuleanu E, Volovat C, Croitoru A, Kakolyris S, Aravantinos G, Ziras N, Athanasiadis E, Touroutoglou N, Pavlidis N, Kalofonos HP, Nasioulas G. Negru S, et al. Among authors: touroutoglou n. BMJ Open. 2014 May 23;4(5):e004652. doi: 10.1136/bmjopen-2013-004652. BMJ Open. 2014. PMID: 24859998 Free PMC article.
Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.
Treon SP, Hansen M, Branagan AR, Verselis S, Emmanouilides C, Kimby E, Frankel SR, Touroutoglou N, Turnbull B, Anderson KC, Maloney DG, Fox EA. Treon SP, et al. Among authors: touroutoglou n. J Clin Oncol. 2005 Jan 20;23(3):474-81. doi: 10.1200/JCO.2005.06.059. J Clin Oncol. 2005. PMID: 15659493 Clinical Trial.
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
Emmanouilides C, Sfakiotaki G, Androulakis N, Kalbakis K, Christophylakis C, Kalykaki A, Vamvakas L, Kotsakis A, Agelaki S, Diamandidou E, Touroutoglou N, Chatzidakis A, Georgoulias V, Mavroudis D, Souglakos J. Emmanouilides C, et al. Among authors: touroutoglou n. BMC Cancer. 2007 May 30;7:91. doi: 10.1186/1471-2407-7-91. BMC Cancer. 2007. PMID: 17537235 Free PMC article. Clinical Trial.